Private company
HESKA CORP
American in vitro and in vivo diagnostic substances company based in Loveland. Summary from the record
Last updated Oct 19, 2026.
Overview
- IndustryIn Vitro & In Vivo Diagnostic Substances2
- HeadquartersLoveland, United States2
- Incorporated inDE3
- Business address3760 Rocky Mountain Avenue, Loveland, Co 805383
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI529900O1OR2EB7L0HY272
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressc/o Business Filings Incorporated, 108 West, 13th Street, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 27339062
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue57¢$146.1M
- Research and development8¢$19.8M
- Other costs33¢$83.8M
- Interest2¢$4.2M
- Income tax1¢$3.4M
Out of $257.3M in revenue.4 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $130.1M5 | $129.3M5 | $127.4M6 | $122.7M7 | $197.3M4 | $253.7M4 | $257.3M4 |
| Cost of revenue | $76.2M8 | $71.1M9 | $70.8M6 | $68.2M7 | $116.0M4 | $147.9M4 | $146.1M4 |
| Gross profit | $53.9M8 | $58.3M9 | $56.6M6 | $54.4M7 | $81.3M4 | $105.8M4 | $111.2M4 |
| Research and development | $2.1M8 | $2.0M9 | $3.3M6 | $8.2M7 | $8.8M4 | $7.0M4 | $19.8M4 |
| Operating expenses | $106.8M4 | $131.5M4 | |||||
| Operating income | $16.5M8 | $18.2M9 | $3.8M6 | $327.0K7 | -$8.2M4 | -$993.0K4 | -$20.3M4 |
| Interest | $160.0K8 | $245.0K9 | $310.0K6 | $3.1M7 | $6.4M4 | $4.2M4 | $4.2M4 |
| Income before tax | -$3.4M4 | -$21.8M4 | |||||
| Income tax | $4.3M8 | $8.9M9 | -$2.1M6 | -$1.4M7 | $239.0K4 | -$3.6M4 | -$3.4M4 |
| Net income | $10.5M8 | $10.0M9 | $5.8M6 | -$1.5M7 | -$14.4M4 | -$1.1M4 | -$19.9M4 |
| Earnings per share | $1.558 | $1.429 | $0.816 | -$0.207 | -$1.664 | -$0.114 | -$1.924 |
| Earnings per share (diluted) | $1.438 | $1.309 | $0.746 | -$0.207 | -$1.664 | -$0.114 | -$1.924 |
| Shares (weighted, basic) | 10.0M shares4 | 10.3M shares4 | |||||
| Shares (weighted, diluted) | 10.0M shares4 | 10.3M shares4 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $10.8M8 | $9.7M8 | $13.4M9 | $89.0M6 | $86.3M7 | $223.6M4 | $156.6M4 |
| Receivables | $28.0M4 | $29.5M4 | |||||
| Inventory | $49.4M4 | $60.0M4 | |||||
| Current assets | $55.3M5 | $62.8M8 | $62.4M9 | $139.9M6 | $171.3M7 | $319.6M4 | $265.0M4 |
| Property, plant and equipment | $33.4M4 | $32.2M4 | |||||
| Goodwill | $118.8M4 | $135.9M4 | |||||
| Intangible assets | $56.7M4 | $62.4M4 | |||||
| Total assets | $130.8M8 | $135.4M9 | $156.5M6 | $244.4M7 | $399.8M4 | $604.1M4 | $585.8M4 |
| Accounts payable | $15.4M4 | $16.4M4 | |||||
| Current liabilities | $32.4M5 | $19.4M8 | $20.4M9 | $32.2M6 | $42.1M7 | $43.9M4 | $39.6M4 |
| Long-term debt | $013 | $6.0M8 | $6.0M9 | $1.1M9 | |||
| Total liabilities | $43.9M5 | $35.0M8 | $34.0M9 | $89.9M6 | $112.8M7 | $168.2M4 | $163.6M4 |
| Retained earnings | -$148.6M4 | -$168.5M4 | |||||
| Shareholders’ equity | $87.0M5 | $100.4M8 | $122.4M9 | $154.4M6 | $287.1M7 | $435.9M4 | $422.2M4 |
| Shares outstanding | 6.6M shares14 | 7.5M shares13 | 7.3M shares5 | 7.7M shares8 | 7.8M shares9 | 9.5M shares6 | 10.8M shares7 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $5.9M8 | $10.4M9 | $13.3M6 | $3.3M7 | -$656.0K4 | $6.2M4 | -$21.8M4 |
| Depreciation and amortization | $13.6M4 | $14.0M4 | |||||
| Stock-based compensation | $18.3M4 | $16.0M4 | |||||
| Capital spending | $3.4M8 | $3.5M9 | $1.4M9 | $1.0M9 | |||
| Free cash flow | $2.4M | $6.9M | $11.9M | $2.3M | |||
| Cash from investing | -$35.0M4 | -$35.8M4 | |||||
| Share buybacks | $762.0K8 | $1.1M9 | $1.3M6 | $3.4M7 | $1.5M4 | $1.6M4 | $5.3M4 |
| Cash from financing | $166.4M4 | -$7.1M4 |
Leadership
Who has led HESKA CORP, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerKevin S. Wilson Dec 2, 2014 to Jun 14, 202315
- Chief executive officerRobert B. Grieve Aug 16, 2006 to Aug 27, 201416
- ChairRobert B. Grieve Jun 5, 2014 to Sep 1, 201517
- PresidentKevin S. Wilson Feb 26, 2013 to Jun 14, 202318
- PresidentMichael J. McGinley Feb 26, 2010 to Nov 25, 201319
- Chief financial officerCatherine Grassman Jun 4, 2019 to Jun 14, 202320
- Chief financial officerJason A. Napolitano Aug 7, 2006 to Sep 1, 201621
- Chief operating officerNancy Wisnewski Mar 10, 2020 to Sep 6, 202222
- Chief operating officerEleanor F. Baker Sep 28, 2020 to Jun 14, 202323
- Chief operating officerJason A. Napolitano Dec 17, 2015 to Feb 20, 201924
- Chief operating officerKevin S. Wilson Feb 26, 2013 to May 8, 201418
- Chief operating officerMichael J. McGinley Feb 26, 2010 to Nov 25, 201319
Board members and other officers (35)
- EVP, Managing Director &Eleanor F. Baker Apr 20, 2020 to Apr 20, 202025
- Chief Strategy OfficerJason A. Napolitano Nov 5, 2019 to Dec 30, 201926
- EVP, International DiagnosticsJason D. Aroesty Apr 27, 2018 to Nov 30, 202027
- VP, CAO & ControllerCatherine Grassman Dec 4, 2017 to Mar 9, 201828
- EVP, Comp. Animal Health SalesRod Lippincott Feb 26, 2013 to Sep 5, 201829
- EVP, Comp. Animal Health SalesSteve Asakowicz Feb 26, 2013 to Aug 28, 201830
- EVP, Commercial OperationsSteven M. Eyl May 17, 2013 to Jun 14, 202331
- VP, MarketingClaudine Zachara May 4, 2011 to May 4, 201132
- EVP, Sales and MarketingJoseph Aperfine May 4, 2011 to Dec 19, 201233
- VP, SalesGerald L. Snodgrass Mar 9, 2007 to Nov 12, 200934
- General Manager, Heska DM &Michael J. McGinley Mar 9, 2007 to Apr 27, 201835
- VP, Prod.Dev.& Tech Cust. ServNancy Wisnewski Mar 9, 2007 to May 14, 201936
- VP, MarketingTodd M. Gilson Mar 9, 2007 to Mar 19, 200737
- EVP, Global Bus. OperationsJoseph H. Ritter Nov 20, 2006 to Jan 3, 200838
- V.P.Actg. Officer & ControllerMichael A. Bent Nov 20, 2006 to Jan 2, 201339
- Board memberJoachim A. Hasenmaier Jan 12, 2021 to Jun 14, 202340
- Board memberRobert L. Antin Nov 18, 2020 to Jun 14, 202341
- Board memberMark F. Furlong Mar 8, 2019 to Jun 14, 202342
- Board memberScott Humphrey Jun 14, 2017 to Jun 14, 202343
- Board memberBonnie J. Trowbridge Jan 28, 2015 to Nov 12, 202044
- Board memberKevin S. Wilson Dec 2, 2014 to Jun 14, 202315
- Board memberCarol Wrenn Jan 3, 2013 to May 7, 201845
- Board memberDavid E. Sveen Nov 26, 2013 to Jun 14, 202346
- Board memberSharon L. Riley Jul 1, 2011 to Jun 14, 202347
- Board memberLouise L. McCormick Jan 3, 2008 to May 10, 201248
- Board memberA. Barr Dolan Mar 1, 2006 to May 8, 200749
- Board memberElisabeth H. Demarse Mar 1, 2006 to Nov 20, 200650
- Board memberJohn F. Sasen Mar 1, 2006 to Feb 14, 201351
- Board memberLynnor B. Stevenson Mar 1, 2006 to May 17, 200652
- Board memberG. Irwin Gordon May 12, 2006 to Dec 3, 201853
- Board memberPeter Eio May 12, 2006 to May 10, 201254
- Board memberWilliam A. Aylesworth May 12, 2006 to Mar 11, 201555
- Board memberRobert B. Grieve Aug 16, 2006 to Aug 27, 201416
- General counselChristopher D. Sveen Apr 20, 2020 to Jun 14, 202356
- General counselJohn R. Flanders Dec 12, 2006 to Nov 28, 200857
Timeline
Filings
136 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 19 major events, 50 insider forms, 11 large holders, 49 other. The latest 20:
- Jun 23, 202315-12G EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 14, 20234 EDGAR
- Jun 13, 2023EFFECT EDGAR
- Jun 13, 2023EFFECT EDGAR
- Jun 13, 202325-NSE EDGAR
- Jun 13, 2023S-8 POS EDGAR
- Jun 13, 2023S-8 POS EDGAR
- Jun 13, 2023S-8 POS EDGAR
The 136 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
5 open-market trades by officers, directors and large owners since October 2021: 4 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 6, 2023 | Wilson Kevin S.CEO and President | Buy | 11,018 | $58.62 | $645.9K | Form 4 |
| Dec 22, 2022 | Wilson Kevin S.CEO and President | Buy | 3,440 | $59.64 | $205.2K | Form 4 |
| Mar 3, 2022 | Baker Eleanor F.EVP, Managing Dir. & COO, scil | Sale | 663 | $146.34 | $97.0K | Form 4 |
| Nov 23, 2021 | Wilson Kevin S.CEO and President | Buy | 1,000 | $173.00 | $173.0K | Form 4 |
| Nov 15, 2021 | Wilson Kevin S.CEO and President | Buy | 1,000 | $179.00 | $179.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Nine Ten Capital Management LLCSC 13G/A, 3 filings Feb 9, 2022 to Apr 10, 202358
- ALGER ASSOCIATES INCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202359
- VANGUARD GROUP INCSC 13G/A, 2 filings Feb 10, 2022 to Feb 9, 202360
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARHESKA CORP filings on SEC EDGAR
- 2
- 3SEC EDGARHESKA CORP filings on SEC EDGAR
- 4SEC EDGARHESKA CORP 10-K for fiscal 2022
- 5SEC EDGARHESKA CORP 10-K for fiscal 2016
- 6SEC EDGARHESKA CORP 10-K for fiscal 2018
- 7SEC EDGARHESKA CORP 10-K for fiscal 2019
- 8SEC EDGARHESKA CORP 10-K for fiscal 2016
- 9SEC EDGARHESKA CORP 10-K for fiscal 2017
- 10SEC EDGARHESKA CORP 10-Q for fiscal 2022
- 11SEC EDGARHESKA CORP 10-Q for fiscal 2022
- 12SEC EDGARHESKA CORP 10-Q for fiscal 2023
- 13SEC EDGARHESKA CORP 10-K for fiscal 2016
- 14SEC EDGARHESKA CORP 10-K for fiscal 2016
- 15
- 16
- 17SEC EDGARRobert B. Grieve, Chair
- 18SEC EDGARKevin S. Wilson, President
- 19SEC EDGARMichael J. McGinley, President
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32SEC EDGARClaudine Zachara, VP, Marketing
- 33
- 34SEC EDGARGerald L. Snodgrass, VP, Sales
- 35
- 36
- 37SEC EDGARTodd M. Gilson, VP, Marketing
- 38
- 39
- 40SEC EDGARJoachim A. Hasenmaier, Board member
- 41SEC EDGARRobert L. Antin, Board member
- 42SEC EDGARMark F. Furlong, Board member
- 43SEC EDGARScott Humphrey, Board member
- 44SEC EDGARBonnie J. Trowbridge, Board member
- 45SEC EDGARCarol Wrenn, Board member
- 46SEC EDGARDavid E. Sveen, Board member
- 47SEC EDGARSharon L. Riley, Board member
- 48SEC EDGARLouise L. McCormick, Board member
- 49SEC EDGARA. Barr Dolan, Board member
- 50SEC EDGARElisabeth H. Demarse, Board member
- 51SEC EDGARJohn F. Sasen, Board member
- 52SEC EDGARLynnor B. Stevenson, Board member
- 53SEC EDGARG. Irwin Gordon, Board member
- 54SEC EDGARPeter Eio, Board member
- 55SEC EDGARWilliam A. Aylesworth, Board member
- 56
- 57SEC EDGARJohn R. Flanders, General counsel
- 58
- 59
- 60